Shoulder Innovations, Inc.

NYSE:SI

Medical - Specialties

Healthcare
$20.65 -0.72%

-$0.13 today

Market cap
$432.04M
Beta
-1.07
P/E (TTM)
-8.4
EPS (TTM)
-$2.13
52W Low $10.92High $19.79

Volume 0.09M

Average 0.10M

SI Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Shoulder Innovations, Inc.NYSE: SI

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 20.65M shares rose 3.7% year over year, ahead of the +3.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.2% from the prior quarter.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly growth of +3.7% holds above the trailing-twelve-month pace of +3.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
20.65M+0.2% QoQ
Last fiscal yearDec 2025
20.63M+3.5% YoY
LTMMar 2026
20.52M+3.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.7%——
1 year+3.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
20.63M USD
Year-over-year change
+3.5%
2-year CAGR
+1.8%

Weighted Avg Shares (Diluted) vs competitors

How SI compares with its peers on the latest reported figures

  • SI's LTM Mar 2026 weighted avg shares (diluted) of 20.52M shares is the 8th highest of the 11 companies compared; the peer median is 24.37M shares.
  • Its year-over-year change of +3.0% is the 7th highest of 11, against a peer median of +11.3%.
SI Competitors Peer median
Weighted Avg Shares (Diluted) for SI and competitors
Company Period LTM YoY 3-year CAGR
NAUTNautilus Biotechnology, Inc.LTM Mar 2026126.35M +0.5%+0.4%
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
MDXHMDxHealth S.A.FY202550.03M +2.8%+46.6%
EPRXEupraxia Pharmaceuticals Inc.LTM Mar 202645.37M +27.3%+27.5%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
AARDAardvark Therapeutics, Inc. Common StockLTM Mar 202621.77M +1.1%+0.7%
ENTAEnanta Pharmaceuticals, Inc.LTM Mar 202621.37M +0.6%+1.2%
SIShoulder Innovations, Inc.LTM Mar 202620.52M +3.0%—
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
ASMBAssembly Biosciences, Inc.LTM Mar 202610.86M +66.5%+40.6%
SNWVSANUWAVE Health, Inc.LTM Mar 20269M +86.9%+83.7%
Peer median (excluding SI) 24.37M+11.3%+17.5%

Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue19.27M31.62M47.32M
Cost of Revenue4M7.28M11.12M
Gross Profit15.27M24.34M36.2M
Gross Margin79.2%77.0%76.5%
Research & Development3.02M4.49M7.73M
Selling, General & Admin23.11M34.51M54.77M
Operating Expenses26.13M38.99M62.5M
Depreciation & Amortization1.64M2.2M3.21M
EBITDA(10.25M)(12.11M)(37.08M)
EBITDA Margin-53.2%-38.3%-78.4%
Operating Income(10.86M)(14.65M)(26.3M)
Operating Margin-56.4%-46.3%-55.6%
Interest Income000
Interest Expense761K1.32M70K
Other Income / Expenses(1.79M)(966K)(14.06M)
Income Before Tax(12.66M)(15.62M)(40.36M)
Pre-Tax Margin-65.7%-49.4%-85.3%
Income Tax Expense000
Net Income(12.66M)(15.62M)(40.36M)
Net Margin-65.7%-49.4%-85.3%
EPS (Basic)(0.63)(0.77)(1.96)
EPS (Diluted)(0.63)(0.77)(1.96)
Weighted Avg Shares19.92M19.92M20.63M
Weighted Avg Shares (Diluted)19.92M19.92M20.63M

Shoulder Innovations, Inc.

NYSE:SI

Intrinsic Alpha fair value

Locked

Current Price

$20.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.